Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × apixaban × Clear all

Phase

Status

Completed 6 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thromboprophylaxis 1

Interventions

Capecitabine 23 Paclitaxel 20 Oxaliplatin 17 Gemcitabine 15 Drug Therapy 15 Docetaxel 15 Fluorouracil 14 Cisplatin 14 Carboplatin 14 Leucovorin 12 pembrolizumab 11 Irinotecan 10 tislelizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Injections 9 Specimen Handling 7 toripalimab 6 Trastuzumab 6 Radiotherapy, Intensity-Modulated 6 Radiation 6 Pemetrexed 6 Cyclophosphamide 6 Bevacizumab 6 sintilimab 5 atezolizumab 5 Temozolomide 5 Standard of Care 5 Azacitidine 5 venetoclax 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡